I now have comprehensive content. Let me compile the full clinical notes.
Diarrhea - Clinical Notes
Primary source: Sleisenger and Fordtran's Gastrointestinal and Liver Disease
1. Definition
Diarrhea is a symptom, not a disease, and may occur in many conditions. Key points:
-
Most patients consider increased fluidity of stool to be the essential characteristic
-
Objective criteria: ≥3 bowel movements per day OR stool weight >200 g/day (in Western countries)
-
Stool weight alone is insufficient - about 20% of patients referred for diarrhea evaluation have normal stool weight but pass small-volume loose stools or more frequent formed stools
-
Fecal incontinence may be mistakenly reported as diarrhea - these patients should be evaluated separately
-
Sleisenger and Fordtran's GI and Liver Disease, p. 204
2. Epidemiology
- In any given month, 7.5% of Americans have symptoms of acute gastroenteritis
- Over 3.5 million outpatient visits for diarrhea occur per year in the USA
- More than 180,000 hospital admissions and 3,000 deaths per year from gastroenteritis
- Chronic diarrhea (liquid stools ≥4 weeks) affects 6.6% of the population annually
- In developing countries, acute infectious diarrhea remains a major cause of morbidity and mortality, especially in children
3. Pathophysiology
Diarrhea results from excess stool water due to abnormal net intestinal water and electrolyte transport.
Normally, the small intestine and colon absorb 99% of the ~9-10 L of fluid passing the ligament of Treitz daily. A reduction of net water absorption by as little as 1% can result in diarrhea.
Three primary mechanisms produce diarrhea:
| Mechanism | Description |
|---|
| Altered mucosal transport | Reduced net water/electrolyte absorption in the small intestine or colon (secretory or osmotic) |
| Rapid transit | Reduces contact time for water absorption, especially in the colon |
| Altered stool consistency | Change in balance between stool water content and insoluble fecal solids (e.g. fiber, bacterial components) that bind water; steatorrhea reduces water-binding capacity |
Water itself is not actively transported - it moves via paracellular and transcellular pathways driven by osmotic gradients created by active ion transport.
4. Clinical Classification
A. By Duration
| Type | Duration | Common Causes |
|---|
| Acute | <4 weeks (often <4 days) | Infections (bacteria, viruses, protozoa, parasites), food poisoning, medications |
| Chronic | ≥4 weeks | IBD, malabsorption, IBS, secretory tumors, medications |
B. By Volume
- Large-volume diarrhea: implies small bowel or proximal colon pathology; large fluid and electrolyte losses
- Small-volume diarrhea: implies distal colon or rectal pathology; often with urgency and tenesmus
C. Osmotic vs. Secretory
| Feature | Osmotic Diarrhea | Secretory Diarrhea |
|---|
| Mechanism | Poorly absorbed solutes draw water into lumen | Active ion secretion or impaired absorption |
| Effect of fasting | Stops with fasting | Continues despite fasting |
| Stool osmotic gap | High (>125 mOsm/kg) | Low (<50 mOsm/kg) |
| Examples | Lactose intolerance, Mg laxatives, osmotic laxatives | VIPoma, carcinoid, bile acid malabsorption, microscopic colitis |
Osmotic gap formula: 290 - 2 × (stool Na + stool K)
In secretory diarrheas, Na/K account for almost all stool osmolality. In osmotic diarrheas, poorly absorbable solutes account for the extra osmolality.
D. Watery vs. Fatty vs. Inflammatory
| Type | Implication | Examples |
|---|
| Watery | Secretory or osmotic process | IBS, microscopic colitis, VIPoma |
| Fatty (steatorrhea) | Defective fat (and nutrient) absorption in small intestine | Celiac disease, pancreatic insufficiency, short bowel |
| Inflammatory (bloody/purulent) | Inflammatory or neoplastic GI disease | IBD (Crohn's, UC), infectious colitis, colorectal cancer |
5. Common Causes by Category
Acute Diarrhea
- Infections: Bacteria (Salmonella, Shigella, Campylobacter, E. coli O157:H7, C. difficile), Viruses (Norovirus, Rotavirus), Protozoa (Giardia, Cryptosporidium, Entamoeba)
- Food poisoning (toxin-mediated: S. aureus, B. cereus)
- Medications
- Food allergy/intolerance
Chronic Diarrhea
- Osmotic: Lactose intolerance, fructose malabsorption, Mg-containing antacids, sugar alcohols (sorbitol)
- Secretory: Microscopic colitis, bile acid malabsorption, VIPoma, carcinoid syndrome, hyperthyroidism
- Inflammatory: IBD (Crohn's disease, ulcerative colitis), infectious colitis, radiation enteritis
- Fatty/malabsorptive: Celiac disease, exocrine pancreatic insufficiency, short bowel syndrome
- Motility disorders: IBS-D, diabetic autonomic neuropathy
- Drug-induced: Antibiotics, chemotherapy, PPIs, NSAIDs, caffeine, erythromycin (motilin receptor agonist)
6. Clinical Evaluation
History
Key features to assess:
- Duration: acute (<4 weeks) vs. chronic (≥4 weeks)
- Onset: congenital, abrupt, gradual
- Pattern: continuous vs. intermittent
- Stool appearance: watery, bloody, fatty/oily, foul-smelling
- Nocturnal diarrhea: strongly suggests organic (not functional) disorder
- Fecal urgency/incontinence: suggests rectal compliance or sphincter problem
- Weight loss: chronic loss suggests malabsorption, IBD, or malignancy
- Diet history: fructose, lactose, sorbitol, fiber intake
- Medications: antibiotics, laxatives, chemotherapy, herbal therapies
- Epidemiology: travel, daycare exposure, raw/undercooked food, well water, immunosuppression
- Symptoms: abdominal pain, bloating, flatulence, fever
Physical Examination
- Assess hydration status (dry mucous membranes, skin turgor, tachycardia, orthostasis)
- Abdominal exam: tenderness, distension, bowel sounds
- Rectal exam: anorectal disease, occult blood
- Signs of systemic disease: thyroid, skin (pyoderma, erythema nodosum), joints, eyes
Key Investigations
For Acute Diarrhea:
- Most self-limiting; investigations only if severe, bloody, febrile, immunocompromised, or prolonged >7 days
- Stool cultures: Salmonella, Shigella, Campylobacter, Yersinia
- C. difficile toxin: in those with colitis or recent antibiotics
- E. coli O157:H7: bloody diarrhea + history of ground beef
- Ova and parasites: travel history, immunocompromised
- Stool WBCs/lactoferrin: distinguishes inflammatory from non-inflammatory
For Chronic Diarrhea:
- Step 1 - Stool characterization: measure fecal fat (72-hr collection or spot test), stool osmotic gap, fecal leukocytes/calprotectin
- Step 2 - Blood tests: CBC, CMP, TSH, CRP/ESR, celiac serology (anti-TTG IgA), vitamin B12/folate
- Step 3 - Imaging: abdominal CT (mass lesion, IBD), small bowel imaging for Crohn's
- Step 4 - Endoscopy: colonoscopy with biopsies (IBD, microscopic colitis, colorectal cancer); upper endoscopy + small bowel biopsy (celiac, Giardia)
- Step 5 - Special tests: 24-hr urine 5-HIAA (carcinoid), VIP levels (VIPoma), SeHCAT scan (bile acid malabsorption)
7. Treatment
Acute Diarrhea
- Rehydration - cornerstone of treatment
- Mild-moderate: oral rehydration solution (ORS) - WHO formula (glucose + Na + K + citrate)
- Severe/unable to tolerate oral: IV fluids (normal saline or lactated Ringer's)
- Diet: BRAT diet (bananas, rice, applesauce, toast) has limited evidence; avoid dairy, fatty foods, caffeine, alcohol
- Antimotility agents: Loperamide for non-bloody, non-febrile diarrhea; contraindicated in invasive infections (risk of toxic megacolon) and C. difficile
- Antibiotics: Only for specific indications:
- Traveler's diarrhea: fluoroquinolone or azithromycin
- Shigellosis: azithromycin or fluoroquinolone
- C. difficile: vancomycin (oral) or fidaxomicin (metronidazole as alternative)
- Giardia: metronidazole or tinidazole
- NOT routinely recommended for most acute bacterial diarrheas (may prolong Salmonella carriage)
- Probiotics: Some evidence for reducing duration of acute infectious diarrhea (Lactobacillus, Saccharomyces boulardii)
Chronic Diarrhea
- Directed at the underlying cause
- Osmotic diarrhea: eliminate the offending agent (lactose, sorbitol, Mg)
- Secretory diarrhea: treat the cause (e.g. bile acid sequestrants for bile acid malabsorption, somatostatin analogues for carcinoid/VIPoma)
- Inflammatory (IBD): aminosalicylates, corticosteroids, immunomodulators, biologics
- Celiac disease: strict gluten-free diet
- Pancreatic insufficiency: pancreatic enzyme replacement
- Microscopic colitis: bismuth subsalicylate, budesonide, cholestyramine
- IBS-D: dietary modification (low FODMAP diet), loperamide, antispasmodics, rifaximin, eluxadoline
- Symptomatic agents: loperamide, diphenoxylate, clonidine (secretory), cholestyramine (bile acid diarrhea), codeine phosphate
8. Complications
| Complication | Details |
|---|
| Dehydration | Most common; can be severe/life-threatening especially in elderly and children |
| Electrolyte disturbances | Hypokalemia, hyponatremia, metabolic acidosis (bicarbonate loss) |
| Malnutrition | Chronic diarrhea - impaired absorption of calories, vitamins, minerals |
| Hemolytic Uremic Syndrome (HUS) | E. coli O157:H7; microangiopathic hemolytic anemia + thrombocytopenia + AKI |
| Toxic megacolon | Severe colitis (IBD, C. difficile); risk increased by antimotility drugs |
| Perianal excoriation | Skin breakdown from frequent loose stools |
9. Special Syndromes
| Syndrome | Key Features |
|---|
| IBS-D | Functional; Rome IV criteria; diarrhea + abdominal pain relieved by defecation; no nocturnal symptoms |
| Microscopic colitis | Normal colonoscopy; diagnosed on biopsy; watery secretory diarrhea; middle-aged women; associated with NSAIDs/PPIs |
| Bile acid malabsorption | After ileal resection/disease; bile acids irritate colon; responds to cholestyramine |
| Postsurgical diarrhea | After cholecystectomy, gastrectomy, vagotomy, bowel resection |
| C. difficile colitis | Antibiotic-associated; pseudomembranes; treat with oral vancomycin or fidaxomicin |
| Traveler's diarrhea | Within 10 days of travel to high-risk area; usually ETEC; self-limited; treat with azithromycin |
| Factitious diarrhea | Laxative abuse; osmotic gap pattern; positive stool alkalinization test (phenolphthalein) |
Sleisenger and Fordtran's GI and Liver Disease, Chapter 16